BioNTech SE

Germany-based biotech company developing immunotherapies and vaccines, known for mRNA platforms and research programs across oncology and infectious diseases.

Mainz, Germany

6772+ employees

www.biontech.com/

An der Goldgrube 12, 55131 Mainz, Germany

Categories:

Immunology, Vaccines & Infectious Disease Solutions

Pharmaceuticals, Biotech & Life Sciences

Genomics, Precision & Personalized Medicine

Business Profile

Capabilities, markets, and positioning.

ISIC Codes

3250

Business Model

manufacturerbrand

Value Chain Role

drug developermanufacturer

Geographies Served

Worldwide

Key Capabilities

mrna-platformimmunologyoncology-pipelineclinical-development

About

BioNTech SE is a life sciences company advancing mRNA and related technologies for vaccines and immune-based medicines.

R&D focus

The company develops product candidates spanning infectious disease prevention and oncology, with platform capabilities designed to generate and optimize antigen-specific immune responses.

Development and manufacturing

BioNTech pairs discovery and clinical development with regulated manufacturing and partner collaboration to move candidates from trials toward commercial supply.

Forum discussions

Threads about BioNTech SE inside the TradeDB forums.

Topics:

All

News

Reviews

Q&A

Help

Guides

Trust

Similar businesses

Other businesses in related categories

Listing disclaimer

Business listings are compiled from publicly available, open-source information, primarily from company websites. Details may be incomplete or out of date. Please verify directly with the business. To request a review or correction, use the report button on this page.